More Botanix Pharmaceuticals Limited news
Botanix Pharmaceuticals LimitedASX: BOT

S&P DJI Announces March 2026 Quarterly Rebalance

Mar 6, 2026 at 6:26 AM EST · Issued by Botanix Pharmaceuticals Limited

Filed with ASX · Mar 6, 2026 at 6:26 AM EST · 7 pages · English

On 6ix: 6ix.com/news/sandp-dji-announces-march-2026-quarterly-rebalance-47

Watch Botanix Pharmaceuticals' latest callBotanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call · Replay · Mar 2↗

Botanix Pharmaceuticals Limited on 6ix

Story so far

  • S&P DJI Announces March 2025 Quarterly RebalanceMar 7, 2025
  • S&P DJI Announces March 2024 Quarterly RebalanceMar 1, 2024

Earlier from Botanix Pharmaceuticals

  • Appendix 4D and Half Year ReportFeb 27
  • Botanix Receives Capital Raise Commitments of A$45 MillionFeb 16
  • Trading HaltFeb 13
  • Pause in TradingFeb 13
  • Botanix Quarterly Activities Report and Appendix 4C Q2 FY26Jan 26

Later from Botanix Pharmaceuticals

  • Successful renegotiation of API supply agreementMar 29
  • Botanix reaches term sheet agreement with 2nd API supplierApr 15
  • Botanix Quarterly Activities Report and Appendix 4C Q3 FY26Apr 28
  • Intention to Grant a European patent on Sofdra applicatorJul 6
  • Notice of Allowance for US patent on Sofdra drug substanceJul 12
All Botanix Pharmaceuticals news releases↗

Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.

Follow Botanix Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer